Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trials Overview
The Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial report consists of 779 trials. The report provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. The report provides top-line data relating to the clinical trials on Acute Renal Failure (ARF). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report includes the names of prominent sponsors involved with conducting the Acute Renal Failure (ARF) clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · Iran · Australia · Germany · India |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · AbbVie Inc
· Am-Pharma BV · Novartis AG · Baxter International Inc · Renibus Therapeutics Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Acute Renal Failure (ARF) Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Acute Renal Failure (ARF) clinical trials landscape with more than 30% of the clinical trials conducted there as of October 2023.
Some of the key regions considered for Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials analysis are Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America.
In a country-wise analysis, as of October 2023, the US accounted for the highest number of Acute Renal Failure (ARF) clinical trials, followed by China and Iran.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, Canada has the highest proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System and Sex Hormones clinical trials as of October 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Brazil has the highest proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System and Sex Hormones clinical trials as of October 2023.
Acute Renal Failure (ARF) Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Acute Renal Failure (ARF) Clinical Trials
Acute Renal Failure (ARF) Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials are company, institution, and the government. As of October 2023, the institution sponsor type dominated the Acute Renal Failure (ARF) clinical trials share, followed by company.
Acute Renal Failure (ARF) Clinical Trials Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Acute Renal Failure (ARF) Clinical Trials
Acute Renal Failure (ARF) Clinical Trials - Competitive Landscape
In 2023, AbbVie Inc. conducted the highest number of Acute Renal Failure (ARF) clinical trials.
Some of the leading companies for Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials are:
- AbbVie Inc
- Am-Pharma BV
- Novartis AG
- Baxter International Inc
- Renibus Therapeutics Inc
Acute Renal Failure (ARF) Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy Full Report to Know More about the Leading Players of Acute Renal Failure (ARF) Clinical Trials
Segments Covered in the Report
Acute Renal Failure (ARF) Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Acute Renal Failure (ARF) Clinical Trials Country Outlook (2023)
- The US
- China
- Iran
- Australia
- Germany
- India
Acute Renal Failure (ARF) Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top level analysis of global clinical trials market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Am-Pharma BV
Novartis AG
Baxter International Inc
Renibus Therapeutics Inc
CTI Clinical Trial and Consulting Inc
Action Pharma A/S (Inactive)
Complexa Inc
DURECT Corp
Fresenius SE & Co KGaA
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Acute Renal Failure (ARF) clinical trials?
Asia-Pacific accounted for the highest number of Acute Renal Failure (ARF) clinical trials as of October 2023.
-
Which country conducted the highest number of Acute Renal Failure (ARF) clinical trials?
The US conducted the highest number of Acute Renal Failure (ARF) clinical trials as of October 2023.
-
Which sponsor type was the most prominent in the Acute Renal Failure (ARF) clinical trials?
The institution was the most prominent sponsor type for Acute Renal Failure (ARF) clinical trials.
-
Who are the leading companies of Acute Renal Failure (ARF) clinical trials?
Some of the leading sponsors of Acute Renal Failure (ARF) clinical trials are AbbVie Inc., Am-Pharma BV, Novartis AG, Baxter International Inc., and Renibus Therapeutics Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.